Literature DB >> 17767160

T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac activator Dock2.

Yoshihiko Tanaka1, Shinjiro Hamano, Kazuhito Gotoh, Yuzo Murata, Yuya Kunisaki, Akihiko Nishikimi, Ryosuke Takii, Makiko Kawaguchi, Ayumi Inayoshi, Sadahiko Masuko, Kunisuke Himeno, Takehiko Sasazuki, Yoshinori Fukui.   

Abstract

The lineage commitment of CD4+ T cells is coordinately regulated by signals through the T cell receptor and cytokine receptors, yet how these signals are integrated remains elusive. Here we find that mice lacking Dock2, a Rac activator in lymphocytes, developed allergic disease through a mechanism dependent on CD4+ T cells and the interleukin 4 receptor (IL-4R). Dock2-deficient CD4+ T cells showed impaired antigen-driven downregulation of IL-4Ralpha surface expression, resulting in sustained IL-4R signaling and excessive T helper type 2 responses. Dock2 was required for T cell receptor-mediated phosphorylation of the microtubule-destabilizing protein stathmin and for lysosomal trafficking and the degradation of IL-4Ralpha. Thus, Dock2 links T cell receptor signals to downregulation of IL-4Ralpha to control the lineage commitment of CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17767160     DOI: 10.1038/ni1506

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  28 in total

Review 1.  Adhesions ring: a structural comparison between podosomes and the immune synapse.

Authors:  Sarah A Wernimont; Christa L Cortesio; William T N Simonson; Anna Huttenlocher
Journal:  Eur J Cell Biol       Date:  2008-03-17       Impact factor: 4.492

2.  STAT3-stathmin interactions control microtubule dynamics in migrating T-cells.

Authors:  Navin K Verma; Jennifer Dourlat; Anthony M Davies; Aideen Long; Wang-Qing Liu; Christiane Garbay; Dermot Kelleher; Yuri Volkov
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

3.  Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.

Authors:  Xia Guo; Ning Shi; Xiao-Bing Cui; Jia-Ning Wang; Yoshinori Fukui; Shi-You Chen
Journal:  Circ Res       Date:  2015-03-18       Impact factor: 17.367

Review 4.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

5.  Differential regulation of IL-4Ralpha expression by antigen versus cytokine stimulation characterizes Th2 progression in vivo.

Authors:  Georgia Perona-Wright; Katja Mohrs; Katrin D Mayer; Markus Mohrs
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

6.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

7.  Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response.

Authors:  Koji Hase; Kazuya Kawano; Tomonori Nochi; Gemilson Soares Pontes; Shinji Fukuda; Masashi Ebisawa; Kazunori Kadokura; Toru Tobe; Yumiko Fujimura; Sayaka Kawano; Atsuko Yabashi; Satoshi Waguri; Gaku Nakato; Shunsuke Kimura; Takaya Murakami; Mitsutoshi Iimura; Kimiyo Hamura; Shin-Ichi Fukuoka; Anson W Lowe; Kikuji Itoh; Hiroshi Kiyono; Hiroshi Ohno
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

8.  Sustained signaling by canonical helper T cell cytokines throughout the reactive lymph node.

Authors:  Georgia Perona-Wright; Katja Mohrs; Markus Mohrs
Journal:  Nat Immunol       Date:  2010-04-25       Impact factor: 25.606

Review 9.  Rho family GTPases and their regulators in lymphocytes.

Authors:  Victor L J Tybulewicz; Robert B Henderson
Journal:  Nat Rev Immunol       Date:  2009-08-21       Impact factor: 53.106

10.  CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway.

Authors:  Kathrin Gollmer; François Asperti-Boursin; Yoshihiko Tanaka; Klaus Okkenhaug; Bart Vanhaesebroeck; Jeffrey R Peterson; Yoshinori Fukui; Emmanuel Donnadieu; Jens V Stein
Journal:  Blood       Date:  2009-05-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.